Year: 2024

DaiichiSankyo-logo

Two Datopotamab Deruxtecan Applications Validated in the EU for Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer or HR Positive, HER2 Negative Breast Cancer

Parallel applications based on TROPION-Lung01 and TROPION-Breast01 phase 3 trial results demonstrating Daiichi Sankyo and AstraZeneca’s datopotamab deruxtecan significantly improved...

Logo_PQE_Group_-_azzurro_-_2023

PDA India Chapter Annual Meeting – Maintaining Quality & Compliance in Pharmaceutical Drug Manufacturing and Regulatory Expectations – Being Held March 11-15, in Hyderabad, India

PQE Group to Sponsor, Present Technical Content Exhibit, and Attend Conference HYDERABAD, India--(BUSINESS WIRE)--PQE Group is excited to join the...